Evidence map›Paper›PMID 27764143›Full record

ArticlePloS one2016

Outcomes in Critically Ill Patients with Cancer-Related Complications.

Viviane B L Torres, Juliana Vassalo, Ulysses V A Silva, Pedro Caruso, André P Torelly, Eliezer Silva, José M M Teles, Marcos Knibel, Ederlon Rezende, José J S Netto and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Understanding Outcomes in Onco-critical Care: The Role of Frailty and Organ Failure.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Critically ill patients with cancer: A clinical perspective.World journal of clinical oncology · 2020
    Review
  12. Review
  13. Characteristics and outcomes of patients with solid tumors receiving chemotherapy in the intensive care unit.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 1 country.

Viviane B L TorresPostgraduate Program in Internal Medicine, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Juliana VassaloPostgraduate Program in Internal Medicine, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Ulysses V A SilvaICU, Fundação Pio XII, Hospital do Câncer de Barretos, Barretos, Brazil.
Pedro CarusoICU, A.C. Camargo Cancer Center, São Paulo, Brazil.
André P TorellyRede Institucional de Pesquisa e Inovação em Medicina Intensiva (RIPIMI), Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
Eliezer SilvaICU, Hospital Israelita Albert Einstein, São Paulo, Brazil.
José M M TelesICU, Hospital Português, Salvador, Brazil.
Marcos KnibelHospital São Lucas, Travessa Frederico Pamplona 32, Rio de Janeiro, Brazil.
Ederlon RezendeICU, Hospital do Servidor Público Estadual, São Paulo, Brazil.
José J S NettoICU, Instituto Nacional de Câncer, Hospital do Câncer II, Rio de Janeiro, Brazil.
Claudio PirasICU, Vitória Apart Hospital, Vitória, Brazil.
Luciano C P AzevedoResearch and Education Institute, Hospital Sírio-Libanês, São Paulo, Brazil.
Fernando A BozzaIDOR, D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
Nelson SpectorPostgraduate Program in Internal Medicine, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Jorge I F SalluhPostgraduate Program in Internal Medicine, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Marcio SoaresPostgraduate Program in Internal Medicine, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Universidade Federal do Rio de Janeiro · BRD’Or Institute for Research and Education · BRAC Camargo Hospital · BRFundação Oswaldo Cruz · BRHospital de Câncer de Barretos · BRHospital do Câncer III · BRHospital do Servidor Público Estadual · BRHospital Estadual Centra · BRHospital Israelita Albert Einstein · BRHospital São Lucas da PUCRS · BRHospital Sírio-Libanês · BRReal Hospital Português · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCancer patients are at risk for severe complications related to the underlying malignancy or its treatment and, therefore, usually require admission to intensive care units (ICU). Here, we evaluated the clinical characteristics and outcomes in this subgroup of patients. MATERIALS AND

methodsSecondary analysis of two prospective cohorts of cancer patients admitted to ICUs. We used multivariable logistic regression to identify variables associated with hospital mortality.

resultsOut of 2,028 patients, 456 (23%) had cancer-related complications. Compared to those without cancer-related complications, they more frequently had worse performance status (PS) (57% vs 36% with PS≥2), active malignancy (95% vs 58%), need for vasopressors (45% vs 34%), mechanical ventilation (70% vs 51%) and dialysis (12% vs 8%) (P<0.001 for all analyses). ICU (47% vs. 27%) and hospital (63% vs. 38%) mortality rates were also higher in patients with cancer-related complications (P<0.001). Chemo/radiation therapy-induced toxicity (6%), venous thromboembolism (5%), respiratory failure (4%), gastrointestinal involvement (3%) and vena cava syndrome (VCS) (2%) were the most frequent cancer-related complications. In multivariable analysis, the presence of cancer-related complications per se was not associated with mortality [odds ratio (OR) = 1.25 (95% confidence interval, 0.94-1.66), P = 0.131]. However, among the individual cancer-related complications, VCS [OR = 3.79 (1.11-12.92), P = 0.033], gastrointestinal involvement [OR = 3.05 (1.57-5.91), P = <0.001] and respiratory failure [OR = 1.96(1.04-3.71), P = 0.038] were independently associated with in-hospital mortality.

conclusionsThe prognostic impact of cancer-related complications was variable. Although some complications were associated with worse outcomes, the presence of an acute cancer-related complication per se should not guide decisions to admit a patient to ICU.

Indexed as

Critical IllnessAgedAntineoplastic AgentsFemaleGastrointestinal DiseasesHematologic DiseasesHospital MortalityHumansIntensive Care UnitsLogistic ModelsMaleMiddle AgedNeoplasmsNeoplasm StagingOdds RatioPrognosisAntineoplastic Agents

Identifiers

PMID27764143
PMCPMC5072702
OpenAlexW2535210722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.